August 02, 2023
Cover Story
36
8
Broader industry shifts may lead outsourcing companies to prioritize integrated services.
August 02, 2023
Development
36
8
Burgeoning CGT modalities bring promise and challenges.
August 02, 2023
Upstream Processing
36
8
Scale-up strategies for cell culture will require a deep understanding of overall bioprocess workflows.
August 01, 2023
Downstream Processing
36
8
Process automation technologies aid modernization and enable closed systems.
August 01, 2023
Manufacturing
36
8
Sourcing of donor cells, access to fit-for-purpose reagents and manufacturing systems, and scalability are top issues.
August 01, 2023
Analytics
36
8
Advanced analytical tools generate more data in today’s labs than ever before.
August 01, 2023
BioBusiness
36
8
Context surrounding the Inflation Reduction Act is necessary for a comprehensive understanding of the global biopharma market.
August 01, 2023
Outsourcing
36
8
More than a third of CMOs are struggling to keep skilled technical and production staff.
August 01, 2023
Regulatory Beat
36
8
Manufacturer lawsuits prompt CMS to [slightly] modify pricing plan.
August 01, 2023
From the CEO
36
8
A proposed database includes key information about critical drugs, such as the country of origin and quantity, so supply chain weaknesses can be identified.
August 01, 2023
From the Editor
36
8
mRNA may be a modality whose chief advances are yet to come.
August 01, 2023
Ask The Expert
36
8
The more information shared, the smoother the approval process, says Susan J. Schniepp, distinguished fellow with Regulatory Compliance Associates.